Open Access

Comparison of Goal-Directed Fluid Therapy Using LiDCOrapid System with Regular Fluid Therapy in Patients Undergoing Spine Surgery as a Randomised Clinical Trial


Cite

Figure 1

CONSORT flow diagram showing the flow of patients through each stage of study.
CONSORT flow diagram showing the flow of patients through each stage of study.

Figure 2

Intraoperative protocol of GDFT in LiDCO group. SVV, stroke volume variation; CO, cardiac output; CI, cardiac index; SV, stroke volume. *If volume loss due to bleeding reaches maximum allowable blood loss (MABL) fluid challange will be stopped and fluid therabhy will be continued with blood transfusion.
Intraoperative protocol of GDFT in LiDCO group. SVV, stroke volume variation; CO, cardiac output; CI, cardiac index; SV, stroke volume. *If volume loss due to bleeding reaches maximum allowable blood loss (MABL) fluid challange will be stopped and fluid therabhy will be continued with blood transfusion.

Figure 3

Base deficit (meq/l) values in two groups.
Base deficit (meq/l) values in two groups.

Figure 4

Comparison of injected crystalloid volume urinary and output in two groups.
Comparison of injected crystalloid volume urinary and output in two groups.

Comparison of peri- and postsurgical complications in two groups of patients

Group Control N (%) LiDCO-Rapid N (%) Total N (%) Probability
Blood transfusion 2 (10) 3 (15) 5 (12.5) 0.633
Myocardial infarction 0 (0) 0(0) 0 (0) -
Stroke 0 (0) 0 (0) 0 (0) -
Pulmonary thromboembolism 0 (0) 0(0) 0 (0) -
Deep vein thrombosis 1 (5) 0(0) 1 (2.5) 0.3
Pneumonia 1 (5) 1(5) 2 (5) 0.100
Pulmonary edema 0 (0) 0 (0) 0 (0) -
Urinary tract infection 0 (0) 0(0) 0 (0) 0.1000
Sepsis 0 (0) 0 (0) 0 (0) -
Acute respiratory distress syndrome 0 (0) 0 (0) 0 (0) -
Acute renal failure 0 (0) 0 (0) 0 (0) -
Postsurgical nausea and vomiting 6 (30) 3 (15) 9 (22.5) 0.256
Reintubation 0 (0) 0 (0) 0 (0) -
Lower extremity nerve defect 0 (0) 0 (0) 0 (0) -
Total complications 11 (55) 6 (30) 17 (42.5) 0.110

Comparing the peri- and postsurgical quantitative variables in two groups

Group N Mean Standard deviation Median IQR Probability
Bleeding (cc) control 20 527.00 273.90 - - 0.916
LiDCO 20 517.50 290.47 - -
Base excess (mEq/L) control 20 −8.25 1.94 - - <0.001
LiDCO 20 −4.75 2.22 - -
Volume (cc) crystalloid control 20 1920.00 584.53 - - 0.001
LiDCO 20 1332.50 409.19 - -
Urine output (cc) control 20 647.50 211.18 - - <0.001
LiDCO 20 377.50 105.72 - -
Hospitalization (day) control 20 - - 2 2–3 0.027*
LiDCO 20 - - 2 1–2
ICU admission (day) control 10 - - 0.5 0–1 0.087*
LiDCO 6 - - 0 0–0.75
Starting solids (hour) control 20 - - 10 8–12 <0.001*
LiDCO 20 - - 7 6–7.5

Preoperative characteristics of patients divided into two groups

Group Control N (%) LiDCO-Rapid N (%) Total N (%) Probability
Sex Female 11 (55) 11(55) 22 (55) 0.624
Male 9 (45) 9 (45) 18 (45)
ASA I 5 (25) 6 (30) 11 (27.5) 0.500
II 15 (75) 14 (70) 29 (72.5)
Hypertension 10 (50) 6 (30) 16 (40) 0.167
Hyperlipidemia 2 (10) 0 (0) 2 (5) 0.244
Diabetes mellitus 5 (25) 2 (10) 7 (17.5) 0.204
Ischemic heart disease 4 (20) 3 (15) 7 (17.5) 0.500
Mitral valve prolapse 0 (0) 1 (5) 1 (2.5) 0.500
Chronic obstructive pulmonary disease 1 (5) 1(5) 2(5) 1.000
eISSN:
2502-0307
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, other, Surgery, Anaesthesiology, Emergency Medicine and Intensive-Care Medicine